EDAN Presented a Regional Development Blueprint for the Delegation from the Colombian Consulate

The Consul General of Colombia in Guangzhou, Hernan Vargas Martin, led a delegation to visit the headquarter of Edan Instruments, Inc. (300206.SZ) in Shenzhen, and exchanged development strategies and actions of Latin American market with Alex You, Global Marketing & Strategic Operations Director, and Eric Li, Senior Regional Manager of EDAN.

“After more than a decade of exploration, the Latin American market has developed into one of EDAN’s most important markets worldwide,” Said Alex, “In particular in Colombia, important outcomes have been achieved including the fruitful cooperation between top medical institutions such as the Central Military Hospital of Bogotá and Clinica Bonnadona Prevenir.”

EDAN initiated a strong long-term cooperation with Colombian medical institutions in 2007. Over 10,000 medical devices have been dispatched in Colombia during the pandemic, and to date, the company has supplied more than 5,000 medical devices annually to the Colombian market.

To further benefit the local users and build a closer relationship, Edan Diagnostics Peru S.A.C. (EDAN Peru) was newly established in Lima, serving as the Latin American operation hub of EDAN, providing timely pre-sale and post-sale support, especially for the Andean Community member countries like Peru, Colombia, Bolivia, Ecuador, etc.

“It’s delighted to notice that EDAN has further development agenda in the region, including establishing more subsidiaries for immediate service and support within reach,” The Consul General pointed out the outstanding growth opportunities in the Andean region and highlighted how collaboration helps achieve future growth, “Colombia has a distinct advantage in labor, tariffs and taxes, which is also in line with EDAN’s future development plans in Latin America. We will also provide more support to well-known medical device brands like EDAN to create a more business-friendly environment.”

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.